Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease. (2023)
Attributed to:
MICA: Pharmacokinetic/Pharmacodynamic (PKPD) Model Development to Inform SARS-CoV-2 Antiviral Development
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-069176
PubMed Identifier: 37550022
Publication URI: http://europepmc.org/abstract/MED/37550022
Type: Journal Article/Review
Volume: 13
Parent Publication: BMJ open
Issue: 8
ISSN: 2044-6055